Q3 2024 · 13F-HR
Avidity Partners Management LPholdings as filed
Filed 2024-11-14 · accession 0001791827-24-000011
$1.96B
Reported value
81
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $80.6M | 4.11% | 962,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $79.9M | 4.07% | 2,917,231 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $72.8M | 3.71% | 148,200 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $70.6M | 3.60% | 556,400 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $62.5M | 3.19% | 1,656,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $62.5M | 3.19% | 985,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $53.0M | 2.70% | 460,000 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $51.1M | 2.61% | 87,400 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $48.0M | 2.45% | 431,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $47.3M | 2.41% | 2,455,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $46.0M | 2.35% | 3,444,002 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $44.9M | 2.29% | 344,900 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $43.5M | 2.22% | 1,373,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $43.2M | 2.20% | 592,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $42.4M | 2.16% | 68,600 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $42.0M | 2.14% | 253,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $41.8M | 2.13% | 752,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $41.1M | 2.10% | 129,700 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $40.1M | 2.04% | 588,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $38.1M | 1.94% | 292,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $36.9M | 1.88% | 1,497,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $35.8M | 1.83% | 790,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $34.1M | 1.74% | 2,132,000 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $32.6M | 1.66% | 1,804,493 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $32.2M | 1.64% | 818,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $31.9M | 1.63% | 1,235,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $29.1M | 1.49% | 315,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $28.5M | 1.45% | 731,104 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $26.7M | 1.36% | 827,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $26.6M | 1.36% | 296,100 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $26.4M | 1.35% | 95,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $25.5M | 1.30% | 562,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $23.8M | 1.21% | 1,800,000 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $23.7M | 1.21% | 500,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $23.2M | 1.19% | 465,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $22.5M | 1.15% | 320,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $20.7M | 1.06% | 38,200 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $20.4M | 1.04% | 308,110 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $19.7M | 1.01% | 100,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $19.4M | 0.99% | 790,926 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $18.9M | 0.96% | 430,900 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $17.8M | 0.91% | 425,041 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $17.8M | 0.91% | 2,133,872 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $17.8M | 0.91% | 119,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $17.2M | 0.88% | 145,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $17.0M | 0.87% | 233,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $17.0M | 0.87% | 293,200 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $16.1M | 0.82% | 240,000 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $14.8M | 0.76% | 1,447,119 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $14.8M | 0.75% | 889,700 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $14.5M | 0.74% | 7,417,155 | Common | SOLE |
| 98978V103 | ZTS | ZOETIS INC | $13.9M | 0.71% | 71,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $13.8M | 0.71% | 749,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $13.6M | 0.70% | 8,266,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $13.6M | 0.69% | 263,000 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $12.8M | 0.65% | 873,891 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $11.9M | 0.61% | 1,132,564 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $10.8M | 0.55% | 1,001,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $9.0M | 0.46% | 154,000 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $8.5M | 0.43% | 466,800 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $8.2M | 0.42% | 918,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $7.3M | 0.37% | 169,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $7.1M | 0.36% | 425,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $6.2M | 0.32% | 200,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $5.9M | 0.30% | 165,000 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $5.8M | 0.29% | 100,000 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $5.0M | 0.25% | 1,465,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $4.3M | 0.22% | 27,600 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $3.9M | 0.20% | 5,026,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $3.3M | 0.17% | 673,618 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.8M | 0.14% | 99,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $2.7M | 0.14% | 240,000 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $2.7M | 0.14% | 694,000 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $2.3M | 0.12% | 1,063,000 | Common | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $2.2M | 0.11% | 1,448,728 | Common | SOLE |
| 45783C200 | TIL | INSTIL BIO INC | $2.0M | 0.10% | 29,100 | Common | SOLE |
| 74065P101 | PRLD | PRELUDE THERAPEUTICS INC | $1.8M | 0.09% | 890,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $1.7M | 0.09% | 2,018,500 | Common | SOLE |
| 44916K106 | HYPR | HYPERFINE INC | $1.3M | 0.07% | 1,188,178 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $847,379 | 0.04% | 1,631,143 | Common | SOLE |
| 14171W202 | — | CAREMAX INC | $36,040 | 0.00% | 21,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.